CDEK
← All organizations
Celator Pharmaceuticals

Celator Pharmaceuticals

For profit

Also known as: CELATOR PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2006

First marketed drug

Aug 3, 2017

Last known activity

Aug 24, 2015

Acquired by Jazz Pharmaceuticals on May 31, 2016

Timeline

1990s

  1. Jan 1, 1999

    Celator Pharmaceuticals— Founded

2010s

  1. May 31, 2016

    Jazz Pharmaceuticals— Acquired By

  2. Aug 3, 2017

    daunorubicin— NDA Secondary Org

  3. Aug 3, 2017

    cytarabine— Marketing Organization

Drugs by trial phase (4 distinct, 10 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (12)

Details

Founded
Princeton, NJ, US Jan 1, 1999
Last known activity
Aug 24, 2015